--- 
study_title: !str:CSV::Cell "A Clinical Evaluation of the Medtronic Endeavor\xC2\xAE Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries with a Reference Vessel Diameter of 2.25 mm to 4.2 mm."
irb_number: !str:CSV::Cell HSC 08-5085
pi_name: !str:CSV::Cell Paul Teirstein
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NCT
research_type: !str:CSV::Cell Cardiology and Vascular Diseases
--- 
study_title: !str:CSV::Cell (NSABP B-31) A Randomized Trial Comparing the Safety and Efficacy of Adriamycin and Cyclophosphamide Followed by Taxol (AC --> T) to that of Adriamycin and Cyclophosphamide Followed by Taxol Plus Herceptin (AC --> T + H) in Node Positive Breast Cancer Patients who have Tumors that Overexpress HER2
irb_number: !str:CSV::Cell HSC-00-111
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00004067
research_type: !str:CSV::Cell Obstetrics and Gynecology
--- 
study_title: !str:CSV::Cell "NSABP C-07: A Clinical Trial Comparing 5-Fluorouracil (5-FU) Plus Leucovorin (LV) and Oxaliplatin with 5-FU Plus LV for the Treatment of Patients With Stages II and III Carcinoma of the Colon"
irb_number: !str:CSV::Cell HSC-00-112
pi_name: !str:CSV::Cell William Miller
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00004931
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell Allogeneic Hematopoietic Progenitor Cell Transplantation from Unrelated Donors
irb_number: !str:CSV::Cell HSC-03-2329
pi_name: !str:CSV::Cell Jeffrey Andrey
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NOTLISTED
research_type: !str:CSV::Cell Hematology and Oncology
--- 
study_title: !str:CSV::Cell Research Database for Hematopoietic Stem Cell Transplantation and Marrow Toxic Injuries
irb_number: !str:CSV::Cell HSC-03-2338
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NCT01166009
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell Research Sample Repository for Allogeneic Hematopoietic Stem Cell Transplantation
irb_number: !str:CSV::Cell HSC-03-2339
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NCT00495300
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell A Trial of Tandem Autologous Stem Cell Transplants + / - Post Second Autologous Transplant Maintenance Therapy versus Single Autologous Stem Cell Transplant Followed by Matched Sibling Nonmyeloablative Allogeneic Stem Cell Transplant for Patients with Multiple Myeloma (BMT-CTN Protocol 0102)
irb_number: !str:CSV::Cell HSC-04-2544
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00075829
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation with Unrelated Donors (An NMDP Protocol)
irb_number: !str:CSV::Cell HSC-05-2825
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NCT00511550
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell Genetic Investigation of Solid Tumors (GIST) Cohort
irb_number: !str:CSV::Cell HSC-07-4835
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NCT01005225
research_type: !str:CSV::Cell Obstetrics and Gynecology
--- 
study_title: !str:CSV::Cell "The PARTNER Trial: Placement of AoRTic TraNscathetER Valves Trial with COHORT B as CONTINUED ACCESS [Edwards Study # 2006-06-US]"
irb_number: !str:CSV::Cell HSC-08-5019
pi_name: !str:CSV::Cell Paul Teirstein
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NCT00530894
research_type: !str:CSV::Cell Cardiology and Vascular Diseases
--- 
study_title: !str:CSV::Cell Project Title:SWOG 9438:Total Body Irradiation, Etoposide, Cyclophosphamide, and Autologous Peripheral Blood Stem Cell Transplantation Followed by Randomization to Therapy with Interleukin-2 Vs. Observation for Patients with Non-Hodgkin's Lymphoma, A BMT Study, Phase III
irb_number: !str:CSV::Cell HSC-99-1437
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00002649
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell A Three-Arm Randomized Trial to Compare Adjuvant Adriamycin and Cyclophosphamide Followed by Taxotere (AC-T); Adriamycin and Taxotere (AT); and Adriamycin. Taxotere, and Cyclophosphamide (ATC) in Breast Cancer Patients with Positive Axillary Lymph Nodes (NSABP Protocol B-30)
irb_number: !str:CSV::Cell HSC-99-1466
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00003782
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell "SWOG 9581: Phase III Randomized Study of Adjuvant Immunotherapy with Monoclonal Antibody 17-1A Versus No Adjuvant Therapy Following Resection for Stage II (Modified Astler-Coller B2) Adenocarcinoma of the Colon"
irb_number: !str:CSV::Cell HSC-99-1594
pi_name: !str:CSV::Cell William Miller
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00002968
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell A Double-Blind, Randomized Phase II Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo in Ovarian Epithelial Cancer or Primary Peritoneal Cancer Patients who have achieved a Complete Clinical Response after Standard Platinum/Taxane Containing Chemotherapy (Bayer 12007)
irb_number: !str:CSV::Cell IRB-09-5125
pi_name: !str:CSV::Cell Bridgette Duggan
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00791778
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell "A Multinational, Randomized, Double-blind Study, Comparing the Efficacy of Aflibercept Once Every 2 Weeks versus Placebo in Patients with Metastatic Colorectal Cancer (MCRC) Treated with Irinotecan / 5-FU Combination (FOLFIRI) after failure of an oxaliplatin based regimen(VELOUR) (Protocol: EFC10262)"
irb_number: !str:CSV::Cell IRB-09-5225
pi_name: !str:CSV::Cell Darren Sigal
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NCT00561470
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell |
  A phase III, randomized, double-blind, placebo-controlled multi-center study of ASA404 in combination with docetaxel in second-line treatment of patients with locally advanced or metastatic (Stage IIIb/IV) non-small cell lung cancer (NSCLC) [Novartis CASA404A2302]

irb_number: !str:CSV::Cell IRB-09-5244
pi_name: !str:CSV::Cell Michael Kosty
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00738387
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell "A Multi-center, Phase 2, Single-Arm, Open-Label Exploratory Study of Individually-Optimized Conditioning Using Pharmacokinetics [PK]-directed Dose Adjustment of Once Daily Intravenous Busulfan, Followed by Autologous Hematopoietic Stem Cell Transplant in Subjects with Non-Hodgkin\xE2\x80\x99s Lymphoma and Hodgkin\xE2\x80\x99s Lymphoma, Otsuka Protocol No. 273-08-201"
irb_number: !str:CSV::Cell IRB-09-5361
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NCT00948090
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell "A Randomized Double-Blind, Placebo-Controlled Study of Everolimus in Combination with Exemestane in the Treatment of Postmenopausal Women with Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer who are refractory to Letrozole or Anastrozole [Protocol: CRAD001Y2301]"
irb_number: !str:CSV::Cell IRB-10-5417
pi_name: !str:CSV::Cell Rajesh Belani
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00863655
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell Randomized, Open-Label, Phase 3 Study of Pemetrexed plus Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients with Advanced Non-Small Cell Lung Cancer of Nonsquamous Histology [H3E-US-S130]
irb_number: !str:CSV::Cell IRB-10-5430
pi_name: !str:CSV::Cell Michael Kosty
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NCT00948675
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell A Randomized, Open-Label Phase IIb Trial of Maintenance Therapy with a MUC1 Dendritic Cell Vaccine (CVacTM) for Epithelial Ovarian Cancer Patients in First or Second Remission [Protocol:CAN-003]
irb_number: !str:CSV::Cell IRB-10-5525
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NCT01068509
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell A Randomized Cross-over Phase 2 Study of the Safety and Efficacy of Two Dose Levels of TH-302 in Combination with Gemcitabine Compared with Gemcitabine Alone in Previously Untreated Patients with Locally Advanced Unresectable or Metastatic Pancreatic Adenocarcinoma [Protocol:TH-CR-404]
irb_number: !str:CSV::Cell IRB-10-5543
pi_name: !str:CSV::Cell Darren Sigal
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NCT01144455
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell "A Phase III randomized, double blind, placebo controlled multi-center study of panobinostat for maintenance of response in patients with Hodgkin\xE2\x80\x99s lymphoma who are at risk for relapse after high dose chemotherapy and autologous stem cell transplant (CLBH589E2301)"
irb_number: !str:CSV::Cell IRB-10-5559
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NCT01034163
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell "Randomized Phase 3 Trial of Gemcitabine/Carboplatin With or Without BSI-201(SAR240550) (a PARP1 Inhibitor) in Patients with Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)[Protocol:20090321(EFC11553)] "
irb_number: !str:CSV::Cell IRB-10-5567
pi_name: !str:CSV::Cell Michael Kosty
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NCT01082549
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell A randomized, 3 arm, multicentre, phase III study to evaluate the efficacy and the safety of T-DM1 combined with pertuzumab or T-DM1 combined with pertuzumab-placebo (blinded for pertuzumab), versus the combination of trastuzumab plus taxane, as first line treatment in HER2- positive progressive or recurrent locally advanced or metastatic breast cancer Roche BO22589/TDM4788g ROW
irb_number: !str:CSV::Cell IRB-10-5627
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NCT01120184
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell " A Randomized Phase III Study of Elacytarabine vs. Investigator\xE2\x80\x99s Choice in Patients with Late Stage Acute Myeloid Leukemia [Protocol: CP4055-306]"
irb_number: !str:CSV::Cell IRB-10-5632
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NCT01147939
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell "The PARTNER II TRIAL \xE2\x80\x9CPlacement of AoRTic TraNscathetER\xE2\x80\x9D Valves Trial\xE2\x80\x9D (US) [Edwards Study 2010-12]"
irb_number: !str:CSV::Cell IRB-11-5682
pi_name: !str:CSV::Cell Paul Teirstein
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NCT01314313
research_type: !str:CSV::Cell Cardiology and Vascular Diseases
--- 
study_title: !str:CSV::Cell A Phase III international, randomized, double-blind, double-dummy study to evaluate the efficacy and safety of 300 mg or 600 mg of intravenous zanamivir twice daily compared to 75 mg of oral oseltamivir twice daily in the treatment of hospitalized adults and adolescents with influenza (Protocol NAI114373)
irb_number: !str:CSV::Cell IRB-11-5700
pi_name: !str:CSV::Cell Farhad Shadan
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NCT01231620
research_type: !str:CSV::Cell Pulmonology
--- 
study_title: !str:CSV::Cell "Virtual HDR Cyberknife Radiosurgery for Localized Prostatic Carcinoma: A Phase II Study"
irb_number: !str:CSV::Cell LAJ-06-4342
pi_name: !str:CSV::Cell Donald Fuller
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NCT01045148
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell |
  Scripps Polster Breast Care Center InvestigatioNal GenebanK (PINK)

irb_number: !str:CSV::Cell LAJ-08-8001
pi_name: !str:CSV::Cell Eric Topol
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00945464
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell "A prospective evaluation of Cyberknife Stereotactic Radiosurgery for low and intermediate risk prostate cancer: emulating HDR brachytherapy dosimetry"
irb_number: !str:CSV::Cell MER-07-4836
pi_name: !str:CSV::Cell Donald Fuller
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NCT00643617
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell Nonmyeloablative Allogeneic Stem Cell Transplantation for Patients using Antithymocyte Globulin and with Cladribine-Melphalan or Total Lymphoid Irradiation
irb_number: !str:CSV::Cell SCC-01-499
pi_name: !str:CSV::Cell Jeffrey Andrey
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NCT01272817
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell "NSABP B-35: A Clinical Trial Comparing Anastrozole with Tamoxifen in Postmenopausal Patients with Ductal Carcinoma in Situ (DCIS) Undergoing Lumpectomy with Radiation Therapy"
irb_number: !str:CSV::Cell SCC-03-2138
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00053898
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell An Open-Label Randomized Phase III Study of Intermittent Oral Capecitabine in Combination with Intravenous Oxaliplatin (Q3W) (XELOX) versus Fluorouracil/Leucovorin as Adjuvant Therapy for Patients who have Undergone Surgery for Colon Carcinoma, AJCC/UICC Stage III (Dukes Stage C) [NO16968D]
irb_number: !str:CSV::Cell SCC-03-2179
pi_name: !str:CSV::Cell Darren Sigal
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00069121
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell A Clinical Trial of Adjuvant Therapy Comparing Six Cycles of 5-Flurouracil, Epirubicin and Cyclophosphamide (FEC) to Four Cycles of Adriamycin and Cyclophosphamide (AC), in Patients with Node-Negative Breast Cancer [NSABP B-36]
irb_number: !str:CSV::Cell SCC-04-2503
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00087178
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell A Phase III Clinical Trial Comparing Infusional 5-Fluorouracil (5-FU), Leucovorin, and Oxaliplatin (mFOLFOX6) every two weeks with Bevacizumab to the same Regimen without Bevacizumab for the Treatment of Patients with Resected Stages II and III Carcinoma of the Colon (NSABP C-08)
irb_number: !str:CSV::Cell SCC-04-2589
pi_name: !str:CSV::Cell Darren Sigal
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00096278
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell "NSABP Protocol B-38: A Phase III, Adjuvant Trial Comparing Three Chemotherapy Regimens in Women with Node-Positive Breast Cancer: Docetaxel/Doxorubicin/Cyclophosphamide (TAC); Dose-Dense (DD) Doxorubicin/Cyclophosphamide Followed by DD Paclitaxel (DD AC-->P); DD AC Followed by DD Paclitaxel Plus Gemcitabine (DD AC-->PG)"
irb_number: !str:CSV::Cell SCC-05-2626
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00093795
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer [NSABP B-39]
irb_number: !str:CSV::Cell SCC-05-2727
pi_name: !str:CSV::Cell Ray Lin
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00103181
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell A Phase III Trial Evaluating the Role of Ovarian Function Suppression and the Role of Exemestane Adjuvant Therapies for Premenopausal Women with Endocrine Responsive Breast Cancer (IBCSG 24-02)
irb_number: !str:CSV::Cell SCC-05-2762
pi_name: !str:CSV::Cell Joan Kroener
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00066690
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell A Phase III Randomized, Controlled Trial of Myocet, Trastuzumab and Paclitaxel versus Trastuzumab and Paclitaxel for First Line Therapy of Metastatic Breast Cancer (#STM01-102)
irb_number: !str:CSV::Cell SCC-06-4333
pi_name: !str:CSV::Cell Joan Kroener
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00294996
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell A Randomized, Double-Blind, Placebo-Controlled Phase IIIb Trial Comparing Bevacizumab Therapy with or without Erlotinib after Completion of Chemotherapy with Bevacizumab for the First-Line Treatment of Locally Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer [AVF3671g]
irb_number: !str:CSV::Cell SCC-06-4334
pi_name: !str:CSV::Cell Michael Kosty
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00257608
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell A Clinical Trial Comparing Preoperative Radiation Therapy and Capecitabine with or without Oxaliplatin with Preoperative Radiation Therapy and Continuous Intravenous Infusion of 5-Fluorouracil with or without Oxaliplatin in the Treatment of Patients with Operable Carcinoma of the Rectum (NSABP R-04)
irb_number: !str:CSV::Cell SCC-06-4391
pi_name: !str:CSV::Cell Darren Sigal
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00058474
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell A Phase II Trial of 5-Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) Chemotherapy plus Bevacizumab for Patients with Unresectable Stage IV Colon Cancer and a Synchronous Asymptomatic Primary Tumor (NSABP C-10)
irb_number: !str:CSV::Cell SCC-06-4487
pi_name: !str:CSV::Cell Darren Sigal
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00321828
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell |-
  Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning IndividuaLized Options for Treatment: The TAILORx Trial
  (ECOG PACCT-1 TAILORx)
irb_number: !str:CSV::Cell SCC-06-4531
pi_name: !str:CSV::Cell Joan Kroener
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00310180
research_type: !str:CSV::Cell Hematology and Oncology
--- 
study_title: !str:CSV::Cell A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormone Receptor Positive Breast Cancer (NSABP B-42)
irb_number: !str:CSV::Cell SCC-06-4553
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00382070
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell A Randomized Phase III Trial of Neoadjuvant Therapy in Patients with Palpable and Operable Breast Cancer Evaluating the Effect on Pathologic Complete Response (pCR) of Adding Capecitabine or Gemcitabine to Docetaxel when Administered before AC with or without Bevacizumab and Correlative Science Studies Attempting to Identify Predictors of High Likelihood for pCR with each of the Regimens [NSABP B-40]
irb_number: !str:CSV::Cell SCC-06-4598
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00408408
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study of Adjuvant Lapatinib in Women with Early-Stage ErbB2 Overexpressing Breast Cancer (EGF105485)
irb_number: !str:CSV::Cell SCC-07-4665
pi_name: !str:CSV::Cell Joan Kroener
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00374322
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell "An Observational Study of AVASTIN\xC2\xAE  (Bevacizumab) in Combination with Chemotherapy for Treatment of Metastatic or Locally Advanced and Unresectable Colorectal Cancer and Locally Advanced or Metastatic Non-Small Cell Lung (Excluding Predominant Squamous Cell Histology) [# AVF3991n]"
irb_number: !str:CSV::Cell SCC-07-4681
pi_name: !str:CSV::Cell Michael Kosty
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00388206
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell A Phase III Adjuvant Trial of Sequenced EC + Filgrastim + Epoetin Alfa Followed by Paclitaxel Versus Sequenced AC Followed by Paclitaxel Versus CEF as Therapy for Premenopausal Women and Early Postmenopausal Women Who Have Had Potentially Curative Surgery for Node Positive or High Risk Node Negative Breast Cancer (NCIC MA.21)
irb_number: !str:CSV::Cell SCC-07-4761
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00014222
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell "A Phase II Study of the Monoclonal Antibody CT-011 in Patients with Diffuse Large B-Cell Lymphoma following Autologous Peripheral Blood Stem Cell Transplantation (Protocol # CT-2007-01)"
irb_number: !str:CSV::Cell SCC-07-4799
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00532259
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell "NSABP PROTOCOL B-41:  A Randomized Phase III Trial of Neoadjuvant Therapy for Patients with Palpable and Operable HER2-Positive Breast Cancer Comparing the Combination of Trastuzumab Plus Lapatinib to Trastuzumab and to Lapatinib Administered with Weekly Paclitaxel Following AC Accompanied by Correlative Science Studies to Identify Predictors of Pathologic Complete Response"
irb_number: !str:CSV::Cell SCC-07-4803
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NCT00486668
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell "A Double-Blind, Randomized, Placebo-controlled Phase III Study to Assess the Efficacy of recMAGE-A3 + AS15 Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients with Resectable MAGE-A3-positive Non-Small Cell Lung Cancer [Protocol #109493]"
irb_number: !str:CSV::Cell SCC-07-4867
pi_name: !str:CSV::Cell Michael Kosty
enrolling: !str:CSV::Cell Yes
nct_num: !str:CSV::Cell NCT00480025
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell A Phase 2, Randomized, Double-Blind, Multicenter Study of Exemestane with and Without SNDX-275 in Postmenopausal Women with Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer, Progressing on Treatment with a Non-Steroidal Aromatase Inhibitor [SNDX-275-0301]
irb_number: !str:CSV::Cell SCC-08-4949
pi_name: !str:CSV::Cell Joan Kroener
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00676663
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell A Phase 2 Open-Label, Multicenter Clinical Study of the Safety and Efficacy of SNS-595 Injection in Patients at Least 60 Years of Age with Previously Untreated Acute Myeloid Leukemia [SPO-0014]
irb_number: !str:CSV::Cell SCC-08-4956
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00607997
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell A Multicenter Phase III Randomized Trial of Adjuvant Therapy for Patients with HER2-Positive Node-Positive or High Risk Node-Negative Breast Cancer Comparing Chemotherapy Plus Trastuzumab with Chemotherapy Plus Trastuzumab Plus Bevacizumab (CIRG(TRIO)011/NSABP B-44-I / B020906)
irb_number: !str:CSV::Cell SCC-08-5012
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00625898
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell An Observational Study of Treatment Patterns and Safety Outcomes for Metastatic or Locally Recurrent Breast Cancer
irb_number: !str:CSV::Cell SCC-08-7005
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00726661
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell "A multicenter, randomized, double-blind, phase 3 study of sunitinib plus prednisone versus prednisone in patients with progressive metastatic castration resistant prostate cancer after failure of a docetaxel-based chemotherapy regimen [Pfizer: A6181120]"
irb_number: !str:CSV::Cell SCC-08-7007
pi_name: !str:CSV::Cell Michael Kosty
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00676650
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell |-
  An Open-label, Single-arm, Phase 2 Study of Carfilzomib
  in Patients with Relapsed and Refractory Multiple
  Myeloma (PX-171-003)
irb_number: !str:CSV::Cell SCC-09-7010
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00511238
research_type: !str:CSV::Cell Oncology and Hematology
--- 
study_title: !str:CSV::Cell Study of Tamoxifen and Raloxifene for the Prevention of Breast Cancer  (STAR)  Protocol NSABP P-2
irb_number: !str:CSV::Cell SCC-99-4159
pi_name: !str:CSV::Cell James Mason
enrolling: !str:CSV::Cell No
nct_num: !str:CSV::Cell NCT00003906
research_type: !str:CSV::Cell Oncology and Hematology
